Broker Recommendations
JP Morgan ups AstraZeneca target price on potential for oncology pipeline
Analysts at JP Morgan hiker their target price for shares of AstraZeneca and pointed to the potential for "significant" future upward revisions to analysts' estimates for the profitability of the company's oncology pipeline.
Canaccord Genuity upgrades Hurricane to 'hold'
Analysts at Canaccord Genuity upgraded exploration and production firm Hurricane Energy from 'sell' to 'hold' on Thursday, stating the group appeared to be "pivoting to better times".
Time is not on the BoE's side, Berenberg says
Bank has its work cut out for it in trying to bring inflation to heel while not tipping the economy into recession, argue economists at Berenberg.
TI Fluid Systems tumbles after Jefferies downgrade
TI Fluid Systems tumbled on Thursday after Jefferies downgraded the shares to ‘hold’ from ‘buy’ and slashed the price target to 195p from 350p.
Berenberg downgrades Polymetal, upgrades Hochschild
Berenberg downgraded Polymetal on Wednesday to ‘hold’ from ‘buy’, citing heightened uncertainty around the Russian assets and saying it has changed its valuation to be based on the NAV of the Kazakh assets alone.
Berenberg reiterates 'buy' rating on Crest Nicholson
Analysts at Berenberg reiterated their 'buy' rating on Crest Nicholson on Wednesday after the group became the first listed housebuilder to sign up to the government's Building Safety Programme.
Deutsche Bank hikes AstraZeneca target price despite rising rate environment
Analysts at Deutsche Bank hiked their target price for shares of AstraZeneca, telling clients they saw no reason to tilt towards so-called 'value' names in the space and away from 'growth'.
Citi expects 'relative re-rating' for select UK homebuilders on 12-month view
Analysts at Citi sounded a 'bullish' note for select UK homebuilders as funding negotiations on legacy cladding concluded.
Berenberg downgrades Vodafone to 'hold'
Berenberg downgraded Vodafone to ‘hold’ from ‘buy’ on Tuesday and trimmed the price target to 145p from 150p, as it said there are simpler investments cases in the sector that are less reliant on M&A execution and offer more upside.
Barclays downgrades Moneysupermarket, sees more upside elsewhere
Barclays downgraded its stance on Moneysupermarket on Tuesday to ‘equalweight’ from ‘overweight’ and slashed the price target to 220p from 260p as it argued there was more upside elsewhere.
JPMorgan starts Darktrace at 'underweight', shares slide
Cybersecurity firm Darktrace was under the cosh on Tuesday as JPMorgan Cazenove initiated coverage of the shares at ‘underweight’, saying the path to sustainable profitable growth was unclear.
Risk-reward in equities not as 'poor' as some believe, J.P.Morgan says
Strategists at J. P. Morgan believe that the risk-reward on offer in equities is not as "poor" as is currently fashionable to argue.
Berenberg lowers target price on Fuller, Smith & Turner
Analysts at Berenberg lowered their target price on pub landlord Fuller, Smith & Turner from 1,000. 0p to 850. 0p on Monday but acknowledged that London's recovery was building steam.
Deutsche Bank upgrades Kingfisher to 'buy'
Deutsche Bank upgraded B&Q owner Kingfisher on Monday to ‘buy’ from ‘hold’, highlighting - among other things - a cheap valuation.
Barclays upgrades Just Group, downgrades Aviva
Just Group rallied on Monday after Barclays upgraded the shares to ‘overweight’ from ‘equalweight’ and lifted the price target to 125p from 106p.
Citi upgrades Bridgepoint, says share price fall overdone
Citi upgraded its stance on private equity firm Bridgepoint on Friday to ‘buy’ from ‘neutral’ as it said the share price fall was overdone.
Liberum upgrades Close Brothers to 'buy'
Liberum upgraded Close Brothers to ‘buy’ from ‘hold’ on Friday, arguing that the recent share price fall was overdone.
Canaccord Genuity lowers target price on Kooth
Analysts at Canaccord Genuity lowered their target price on mental health care specialist Kooth from 470. 0p to 380. 0p on Friday following the firm's results earlier in the week.